Hence, targeting amino acid transporters as an Achilles’ heel of the cancer cells may offer a wide range of opportunities to tackle oxidative stress and sensitize tumor cells to anticancer treatments (Figure 2). This evidence concerns the gene SLC38A7 and cancer.